Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5194629
Max Phase: Preclinical
Molecular Formula: C40H56N10O13S
Molecular Weight: 917.01
Associated Items:
ID: ALA5194629
Max Phase: Preclinical
Molecular Formula: C40H56N10O13S
Molecular Weight: 917.01
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)CNC(=O)[C@@H]2Cc3c([nH]c4ccc(O)cc34)S[C@@H](C)[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H]([C@@H](C)[C@@H](O)CO)C(=O)N2
Standard InChI: InChI=1S/C40H56N10O13S/c1-5-16(2)31-36(60)43-13-30(57)48-33-18(4)64-39-22(21-8-19(52)6-7-23(21)46-39)10-24(34(58)42-12-29(56)47-31)44-37(61)32(17(3)27(54)15-51)49-35(59)26-9-20(53)14-50(26)40(63)25(11-28(41)55)45-38(33)62/h6-8,16-18,20,24-27,31-33,46,51-54H,5,9-15H2,1-4H3,(H2,41,55)(H,42,58)(H,43,60)(H,44,61)(H,45,62)(H,47,56)(H,48,57)(H,49,59)/t16-,17-,18-,20+,24-,25-,26-,27-,31-,32-,33-/m0/s1
Standard InChI Key: IPIQYXUJKLRVGQ-XYSBFCSFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 917.01 | Molecular Weight (Monoisotopic): 916.3749 | AlogP: -4.55 | #Rotatable Bonds: 7 |
Polar Surface Area: 363.81 | Molecular Species: NEUTRAL | HBA: 14 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 23 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.43 | CX Basic pKa: | CX LogP: -5.79 | CX LogD: -5.79 |
Aromatic Rings: 2 | Heavy Atoms: 64 | QED Weighted: 0.12 | Np Likeness Score: 1.07 |
1. Todorovic M, Rivollier P, Wong AAWL, Wang Z, Pryyma A, Nguyen TT, Newell KC, Froelich J, Perrin DM.. (2022) Rationally Designed Amanitins Achieve Enhanced Cytotoxicity., 65 (15.0): [PMID:35696491] [10.1021/acs.jmedchem.1c02226] |
Source(1):